找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Breast Cancer Research and Treatment; Innovative Concepts Ouissam Al Jarroudi,Khalid El Bairi,Giuseppe Curig Book 2023 The Editor(s) (if ap

[復(fù)制鏈接]
樓主: Corrugate
11#
發(fā)表于 2025-3-23 11:24:24 | 只看該作者
https://doi.org/10.1007/978-981-15-9158-7caloric intake. While obesity and elevated body mass index are well-reported critical risk factors of BC occurrence, there is an expanding area of oncology assessing the impact of caloric intake and nutritional patterns in patients with cancer. Caloric restriction and fast mimicking alimentary regim
12#
發(fā)表于 2025-3-23 16:22:26 | 只看該作者
https://doi.org/10.1007/978-981-15-9158-7 standard treatment for HR?+?BC. Most patients, however, eventually develop resistance to ET, which limits their effectiveness and poses a major challenge for the management of HR?+?BC. Several mechanisms that contribute to ET resistance have been described. One of the most common mechanisms is the
13#
發(fā)表于 2025-3-23 21:01:26 | 只看該作者
14#
發(fā)表于 2025-3-23 23:45:12 | 只看該作者
https://doi.org/10.1007/978-981-15-9158-7surgical and radiotherapy techniques improve local control and symptom management, BM remains associated with a poor prognosis. In addition, the efficacy of currently approved systemic therapies in central nervous system (CNS) compartment is still limited, especially after progression on local thera
15#
發(fā)表于 2025-3-24 03:15:50 | 只看該作者
https://doi.org/10.1007/978-981-15-9158-7ent of breast cancer (BC) has increased the numbers of cancer survivors but with the risk of cardiovascular adverse events (CV-AEs). All drugs can potentially damage the cardiovascular system, with different types of clinical manifestations from ischemic myocardial disease to vasculitis, thrombosis
16#
發(fā)表于 2025-3-24 07:24:11 | 只看該作者
Recent Results in Cancer Researchatients. The applications of gene sequencing, including next-generation gene sequencing (NGS), have led to numerous questions on how to validate, implement, interpret, prioritize and operationalize precision medicine tools to deliver meaningful and impactful interventions. Limited benefit has been p
17#
發(fā)表于 2025-3-24 11:49:54 | 只看該作者
18#
發(fā)表于 2025-3-24 14:59:23 | 只看該作者
19#
發(fā)表于 2025-3-24 20:24:31 | 只看該作者
20#
發(fā)表于 2025-3-25 03:15:16 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-8 12:03
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
城固县| 平罗县| 武宣县| 万宁市| 二连浩特市| 图木舒克市| 利辛县| 肥东县| 水城县| 扬州市| 嘉义市| 易门县| 法库县| 深泽县| 洪湖市| 察哈| 南昌市| 天祝| 东丰县| 峡江县| 旬阳县| 宜阳县| 离岛区| 大庆市| 镇平县| 大庆市| 柯坪县| 靖西县| 同心县| 文安县| 本溪市| 尖扎县| 卓资县| 皋兰县| 阜平县| 乌鲁木齐县| 汉阴县| 彭州市| 杂多县| 昌宁县| 太仆寺旗|